Direct costs of Healthcare of multiple Sclerosis, the case of a Health manteinance Organization in Colombia

Abstract

A253the study period. Controls were selected based on a propensity score methodology ensuring exactly the same baseline lung disease distribution between the 2 groups and no medical claim for PH across the entire study period. RESULTS: A total of 2,236 cases met study criteria. On average, cases were significantly (p< 0.01) younger (67 vs. 71), more females (64% vs 58%) and higher comorbid burden (2.8 vs 2.09) compared to controls. After adjusting for all baseline characteristics cases had significantly higher (p< 0.001) inpatient admissions (5.0 vs 2.4), physician office visits (16.5 vs 12.5), emergency room visits (0.7 vs 0.5), pharmacy claims (67 vs 54). This translated into higher expenditures among cases ($42,914) vs controls ($16,745) at per patient per year level. CONCLUSIONS: Using health plan data this study showed that Group 3-PH poses a significant economic burden to payers. PHS36HoSPitalization coStS due to Severe acute reSPiratory infection (Sari) in tHree central american countrieS